316 related articles for article (PubMed ID: 24646225)
21. Perspective: TGR5 (Gpbar-1) in liver physiology and disease.
Keitel V; Häussinger D
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):412-9. PubMed ID: 22521118
[TBL] [Abstract][Full Text] [Related]
22. Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line.
Mobraten K; Haugbro T; Karlstrom E; Kleiveland CR; Lea T
J Recept Signal Transduct Res; 2015; 35(5):402-9. PubMed ID: 25418122
[TBL] [Abstract][Full Text] [Related]
23. The Bile Acid Receptor TGR5 and Liver Regeneration.
Jourdainne V; Péan N; Doignon I; Humbert L; Rainteau D; Tordjmann T
Dig Dis; 2015; 33(3):319-26. PubMed ID: 26045264
[TBL] [Abstract][Full Text] [Related]
24. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
25. The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.
Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29084156
[TBL] [Abstract][Full Text] [Related]
26. Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice.
Hunt JE; Hartmann B; Schoonjans K; Holst JJ; Kissow H
Front Endocrinol (Lausanne); 2021; 12():640602. PubMed ID: 33716991
[TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice.
Morimoto K; Watanabe M; Sugizaki T; Irie J; Itoh H
Endocrinology; 2016 Mar; 157(3):1071-81. PubMed ID: 26789236
[TBL] [Abstract][Full Text] [Related]
29. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A; Maiti P
Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
[TBL] [Abstract][Full Text] [Related]
30. Role of TGR5 (GPBAR1) in Liver Disease.
Keitel V; Häussinger D
Semin Liver Dis; 2018 Nov; 38(4):333-339. PubMed ID: 30357770
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Ro Ameliorates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein-Coupled Bile Acid Receptor 5 Pathway.
Jiang LS; Li W; Zhuang TX; Yu JJ; Sun S; Ju ZC; Wang ZT; Ding LL; Yang L
J Pharmacol Exp Ther; 2021 Jun; 377(3):441-451. PubMed ID: 33820830
[TBL] [Abstract][Full Text] [Related]
32. Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats.
Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
Biomed Pharmacother; 2017 Nov; 95():599-604. PubMed ID: 28881290
[TBL] [Abstract][Full Text] [Related]
33. Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
Miyazaki-Anzai S; Masuda M; Levi M; Keenan AL; Miyazaki M
PLoS One; 2014; 9(9):e108270. PubMed ID: 25237811
[TBL] [Abstract][Full Text] [Related]
34. Bile acid receptors and the kidney.
Herman-Edelstein M; Weinstein T; Levi M
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):56-62. PubMed ID: 29045336
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.
Kim K; Park M; Lee YM; Rhyu MR; Kim HY
Arch Pharm Res; 2014; 37(9):1193-200. PubMed ID: 24590628
[TBL] [Abstract][Full Text] [Related]
36. TGR5-mediated bile acid sensing controls glucose homeostasis.
Thomas C; Gioiello A; Noriega L; Strehle A; Oury J; Rizzo G; Macchiarulo A; Yamamoto H; Mataki C; Pruzanski M; Pellicciari R; Auwerx J; Schoonjans K
Cell Metab; 2009 Sep; 10(3):167-77. PubMed ID: 19723493
[TBL] [Abstract][Full Text] [Related]
37. Bile acid signaling in renal water regulation.
Li S; Li C; Wang W
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
[TBL] [Abstract][Full Text] [Related]
38. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
Prawitt J; Caron S; Staels B
Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
[TBL] [Abstract][Full Text] [Related]
39. Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases.
Xu Y
J Med Chem; 2016 Jul; 59(14):6553-79. PubMed ID: 26878262
[TBL] [Abstract][Full Text] [Related]
40. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.
Pols TW; Noriega LG; Nomura M; Auwerx J; Schoonjans K
J Hepatol; 2011 Jun; 54(6):1263-72. PubMed ID: 21145931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
